BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12722275)

  • 1. [Leprosy].
    Ishii N; Sasaki S
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():531-5. PubMed ID: 12722275
    [No Abstract]   [Full Text] [Related]  

  • 2. [New WHO recommendations for the treatment of leprosy].
    Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
    [No Abstract]   [Full Text] [Related]  

  • 3. Multidrug therapy (MDT) and leprosy control.
    Noordeen SK
    Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
    [No Abstract]   [Full Text] [Related]  

  • 4. Should large lesions of leprosy be considered as "multibacillary" for treatment purposes even if the total number of lesions is less than five?
    Kumarasinghe SP; Kumarasinghe MP
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):173-4. PubMed ID: 15301583
    [No Abstract]   [Full Text] [Related]  

  • 5. Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
    Lockwood DN; Cunha Mda G
    Lepr Rev; 2012 Sep; 83(3):241-4. PubMed ID: 23356024
    [No Abstract]   [Full Text] [Related]  

  • 6. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of leprosy.
    Kar HK; Gupta R
    Clin Dermatol; 2015; 33(1):55-65. PubMed ID: 25432811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Painless Nodular Rash in a Young Man.
    Bass M; Foster K; Studdiford J
    Am Fam Physician; 2017 Aug; 96(3):189-190. PubMed ID: 28762689
    [No Abstract]   [Full Text] [Related]  

  • 9. Multidrug therapy regimen for leprosy.
    Firooz A
    J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
    Sansarricq H
    Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
    [No Abstract]   [Full Text] [Related]  

  • 11. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
    Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
    Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the diagnosis and treatment of leprosy.
    Moschella SL
    J Am Acad Dermatol; 2004 Sep; 51(3):417-26. PubMed ID: 15337986
    [No Abstract]   [Full Text] [Related]  

  • 13. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
    Ganapati R; Revankar CR; Pai VV; Kingsley S
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combination chemotherapy in leprosy].
    Leiker DL
    Ned Tijdschr Geneeskd; 1986 Oct; 130(43):1926-9. PubMed ID: 3774040
    [No Abstract]   [Full Text] [Related]  

  • 15. [How should leprosy be treated?].
    Mahé A
    Ann Dermatol Venereol; 1998 Dec; 125(12):881-3. PubMed ID: 9922859
    [No Abstract]   [Full Text] [Related]  

  • 16. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV; Bulchand HO; Revankar CR; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract]   [Full Text] [Related]  

  • 17. Shiny red-brown papules in a 21-year-old man. Histoid leprosy.
    Aranda J; Hoang MP; Cohen JB
    Arch Dermatol; 2004 Jun; 140(6):751-6. PubMed ID: 15210473
    [No Abstract]   [Full Text] [Related]  

  • 18. Why multidrug therapy for multibacillary leprosy can be shortened to 12 months.
    Ji B
    Lepr Rev; 1998 Jun; 69(2):106-9. PubMed ID: 9715593
    [No Abstract]   [Full Text] [Related]  

  • 19. The future of leprosy in the Dominican Republic: experience with multidrug therapy.
    Martinez Cruz D
    Lepr Rev; 1986; 57 Suppl 3():127-33. PubMed ID: 3573953
    [No Abstract]   [Full Text] [Related]  

  • 20. Some considerations on the origin of type 1 reactions in leprosy.
    Opromolla DV
    Int J Lepr Other Mycobact Dis; 2005 Mar; 73(1):33-4. PubMed ID: 15898839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.